Biomarkers for the clinical management of breast cancer: International perspective
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for the clinical management of breast cancer: International perspective
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 1, Pages 1-13
Publisher
Wiley
Online
2012-12-22
DOI
10.1002/ijc.27997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modification and Implementation of NCCN Guidelines™ on Breast Cancer in the Middle East and North Africa Region
- (2017) Omalkhair Abulkhair et al. Journal of the National Comprehensive Cancer Network
- HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
- (2012) Christian Widakowich et al. Anti-Cancer Agents in Medicinal Chemistry
- Personalized Medicine: The Road Ahead
- (2012) Rutika Mehta et al. Clinical Breast Cancer
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- (2012) Takayuki Iwamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel
- (2011) Eva J Kantelhardt et al. BMC CANCER
- Prognostic role of CA15.3 in 7942 patients with operable breast cancer
- (2011) M. T. Sandri et al. BREAST CANCER RESEARCH AND TREATMENT
- Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
- (2011) Laura J. Esserman et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple Negative and Basal-like Breast Cancer in East Africa
- (2011) Mateya E. Trinkaus et al. Breast Journal
- A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer
- (2011) T J Molloy et al. BRITISH JOURNAL OF CANCER
- Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
- (2011) J. A. Shaw et al. GENOME RESEARCH
- Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
- (2011) Angela Gradilone et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
- (2011) Angelo Di Leo et al. LANCET ONCOLOGY
- Quality assessment of HER2 testing by monitoring of positivity rates
- (2011) Harald Choritz et al. VIRCHOWS ARCHIV
- Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
- (2010) Helen M. Heneghan et al. ANNALS OF SURGERY
- The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
- (2010) Michael Knauer et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
- (2010) Ruth E. Board et al. BREAST CANCER RESEARCH AND TREATMENT
- Combinatorial biomarker expression in breast cancer
- (2010) Emad A. Rakha et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating Tumor Nucleic Acids: Perspective in Breast Cancer
- (2010) Ida Casciano et al. Breast Care
- Inflammatory breast cancer in Tunisia
- (2010) Hamouda Boussen et al. CANCER
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer
- (2010) R. Molina et al. CLINICAL CHEMISTRY
- Circulating tumour-derived predictive biomarkers in oncology
- (2010) Darren R. Hodgson et al. DRUG DISCOVERY TODAY
- Current and emerging biomarkers in breast cancer: prognosis and prediction
- (2010) Marion T Weigel et al. ENDOCRINE-RELATED CANCER
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- (2010) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
- (2010) John MS Bartlett et al. LANCET ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial
- (2009) Christine Desmedt et al. BMC Medical Genomics
- Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
- (2009) Hyo Song Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer
- (2009) Edoardo Botteri et al. BREAST CANCER RESEARCH AND TREATMENT
- Re-establishing a surgical pathology service in Kumasi, Ghana
- (2009) Helge Stalsberg et al. CANCER
- Defining a global research agenda for breast cancer
- (2009) Richard R. Love CANCER
- Effective but cost-prohibitive drugs in breast cancer treatment
- (2009) Jose Bines et al. CANCER
- Breast pathology guideline implementation in low- and middle-income countries
- (2009) Shahla Masood et al. CANCER
- Guideline implementation for breast healthcare in low- and middle-income countries
- (2009) Joe Harford et al. CANCER
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Value and Limitations of Measuring HER-2 Extracellular Domain in the Serum of Breast Cancer Patients
- (2009) Alexandra F. Leary et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease-Free Survival According to Degree ofHER2Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
- (2009) Dezheng Huo et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR
- (2009) Michael P Raynor et al. Journal of Hematology & Oncology
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Poor Hormone Receptor Expression in East African Breast Cancer: Evidence of a Biologically Different Disease?
- (2008) P. A. Bird et al. ANNALS OF SURGICAL ONCOLOGY
- Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
- (2008) R. Stuart-Harris et al. BREAST
- The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
- (2008) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
- (2008) M. Dowsett et al. CLINICAL CANCER RESEARCH
- HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
- (2008) M. F. Press et al. CLINICAL CANCER RESEARCH
- A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer
- (2008) X.-J. Ma et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa
- (2008) K D Awadelkarim et al. HISTOPATHOLOGY
- Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
- (2008) Ke-da Yu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy
- (2008) Kathleen I. Pritchard et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
- (2008) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Does Estrogen Receptor–Negative/Progesterone Receptor–Positive Breast Carcinoma Exist?
- (2008) Leen De Maeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
- (2008) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers
- (2008) Stephen Chia et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory
- (2008) Sunil S. Badve et al. JOURNAL OF CLINICAL ONCOLOGY
- The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
- (2008) A Rhodes et al. JOURNAL OF CLINICAL PATHOLOGY
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
- Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
- (2008) Edurne Arriola et al. LABORATORY INVESTIGATION
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Anne Vincent-Salomon et al. NATURE GENETICS
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Jorge S Reis-Filho et al. NATURE GENETICS
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Lindsay A Brown et al. NATURE GENETICS
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Hugo M Horlings et al. NATURE GENETICS
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commentary: Hormone Receptor Testing in Breast Cancer: A Distress Signal from Canada
- (2008) D. C. Allred ONCOLOGIST
- The genome landscape of ER - and ER -binding DNA regions
- (2008) Y. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues
- (2007) A Vincent-Salomon et al. JOURNAL OF CLINICAL PATHOLOGY
- HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
- (2007) Alessandra Gennari et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search